Jerry H. Gurwitz, MD

Articles by Jerry H. Gurwitz, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Shira H. Fischer, AB,Shawn J. Gagne, BA,Daniel J. Peterson, MA, MS,Lawrence D. Garber, MD,Jerry H. Gurwitz, MD

September 7th 2011

Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Lawrence D. Garber, MD,Jennifer L. Donovan, PharmD,Abir O. Kanaan, PharmD,Marsha A. Raebel, PharmD,Yanfang Zhao, MA,Jacquelyne C. Fuller, MPH,Shawn J. Gagne, BA,Shira H. Fischer, AB,Jerry H. Gurwitz, MD

July 17th 2010

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control

ByCynthia J. Willey, PhD,Susan E. Andrade, ScD,Joseph Cohen, MD,Jackie C. Fuller, MPH,Jerry H. Gurwitz, MD

August 1st 2006

Health Plan Members' Views on Forgiving Medical Errors

ByKathleen M. Mazor, EdD,Steven R. Simon, MD,Robert A. Yood, MD,Brian C. Martinson, PhD,Margaret J. Gunter, PhD,George W. Reed, PhD,Jerry H. Gurwitz, MD

January 15th 2005

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice

BySusan E. Andrade, ScD,Jerry H. Gurwitz, MD,Terry S. Field, DSc,Michael Kelleher, MD,Sumit R. Majumdar, MD, MPH,George Reed, PhD,Robert Black, MD

July 1st 2004

Latest Updated Articles

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice
July 1st 2004
Health Plan Members' Views on Forgiving Medical Errors
January 15th 2005
Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control
August 1st 2006
Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting
July 17th 2010
Quality Measurement of Medication Monitoring in the Meaningful Use Era
September 7th 2011

Jerry H. Gurwitz, MD

Articles by Jerry H. Gurwitz, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control

Health Plan Members' Views on Forgiving Medical Errors

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice

Latest Updated Articles

Trending on AJMC

Patient Portal Messages Outpace Office Visits

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Jerry H. Gurwitz, MD

Articles by Jerry H. Gurwitz, MD

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Polypharmacy With Oral Antidiabetic Agents: An Indicator of Poor Glycemic Control

Health Plan Members' Views on Forgiving Medical Errors

Hypertension Management: The Care Gap Between Clinical Guidelines and Clinical Practice

Latest Updated Articles

Trending on AJMC

Patient Portal Messages Outpace Office Visits

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk